Biostatistics/Epidemiology Training Grants in AIDS
 


Directors & Preceptors






DIRECTORS

Giovanni Parmigiani, is a Professor of Biostatistics at Harvard School of Public Health, the Chairman of the Department of Biostatistics and Computational Biology at Dana-Farber Cancer Institute, and the Associate Director for Population Sciences of the Dana-Farber / Harvard Cancer Center. He is trained in statistics. His research focuses on development and application of statistical tools for cancer research, with particular focus on genetic epidemiology and genomics. His lab developed algorithms for familial risk prediction (BRCAPRO, MMRpro, MelaPro and PancPro) licensed to over six thousand users worldwide. He has been the main statistician and one of the senior authors for the breast, colon, pancreas, and glioblastoma cancer genome projects with the Vogelstein-Kinzler-Velculascu lab. His ongoing genomics research include preprocessing, tools for cross-study reproducibility, and gene set analysis. Methodologically he has be active in exploratory data analysis, Bayesian modeling and decision theory. He has mentoring mentored more than twenty PhD students and twenty postdoctoral fellows. Additional details about his activities can be found at http://bcb.dfci.harvard.edu/~gp.


PRECEPTORS

Hans-Olov Adami, M.D., Ph.D.; Chair, Department of Epidemiology, and Professor of Epidemiology, Harvard School of Public Health.

Vincent Carey, Ph.D.; AAssociate Professor of Medicine, Harvard Medical School.

Paul Catalano, Sc.D.; Senior Lecturer in Biostatistics, Harvard School of Public Health, and Associate Chair, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute.

Dianne Finkelstein, Ph.D.; Professor in the Department of Biostatistics, Harvard School of Public Health, Professor of Biostatistics in the Department of Medicine, Harvard Medical School, and Director of Biostatistics, Mass General Hospital Cancer Center.

Richard Gelber, Ph.D.; Professor in the Department of Biostatistics, Harvard School of Public Health, and Professor of Pediatrics (Biostatistics), Harvard Medical School.

Rebecca Gelman, Ph.D.; Associate Professor in the Department of Biostatistics, Harvard School of Public Health, and Associate Professor of Biostatistics in the Department of Radiation Onocology, Harvard Medical School and Dana-Farber Cancer Institute.

Edward Giovannucci, M.D., Sc.D.; Professor of Nutrition and Epidemiology, Harvard School of Public Health, and Associate Professor of Medicine, Harvard Medical School.

Robert Gray, Ph.D.; Professor of Biostatistics, Harvard School of Public Health and Dana-Farber Cancer Institute.

Susan Hankinson, M.P.H., Sc.D.; Professor in the Department of Epidemiology, Harvard School of Public Health

David Harrington, Ph.D.; Professor of Biostatistics, Harvard School of Public Health and Dana-Farber Cancer Institute.

Steven Joffe, M.D., M.P.H.; Assistant Professor of Pediatrics, Harvard Medical School and Dana-Farber Cancer Institute.

Cheng Li, Ph.D.; Associate Professor of Biostatistics, Harvard School of Public Health and Dana-Farber Cancer Institute.

Xiaole Shirley Liu, Ph.D.; Associate Professor of Biostatistics, Harvard School of Public Health and Dana-Farber Cancer Institute.

Massimo Loda, M.D.; Professor of Pathology, Harvard Medical School, and Director, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute / Brigham and Women’s Hospital.

Wendy London, Ph.D.; Associate Professor, Department of Medicine, Harvard Medical School, Director of Biostatistics (Medicine), Children's Hospital Boston, and Co-Director, Clinical Translational Investigation Program, Pedatric Hematology/Oncology, Dana-Farber Cancer Institute.

Cyrus Mehta, Ph.D.; Adjunct Professor of Biostatistics, Harvard School of Public Health, and President, Cytel Software Corporation.

Matthew Meyerson, M.D., Ph.D.; Professor of Pathology, Harvard Medical School and Dana-Farber Cancer Institute.

Nikhil Munshi, M.D.; Associate Professor of Medicine, Harvard Medical School and Dana-Farber Cancer Institute.

George Mutter, M.D.; Associate Professor of Pathology, Harvard Medical School and Associate Pathologist, Brigham and Women's Hospital.

Donna Neuberg, Sc.D.; Senior Lecturer on Biostatistics, Harvard School of Public Health and Dana-Farber Cancer Institute.

John Quackenbush, Ph.D.; Professor of Computational Biology and Bioinformatics, Harvard School of Public Health and Dana-Farber Cancer Institute.

Meredith Regan, Sc.D.; Assistant Professor of Medicine, Harvard Medical School / Brigham and Women's Hospital, and Senior Research Scientist, Dana-Farber Cancer Institute.

Bernard Rosner, Ph.D.; Professor in the Department of Biostatistics, Harvard School of Public Health, and Professor of Medicine (Biostatistics), Harvard Medical School.

Deborah Schrag, M.D., M.P.H.; Attending Physician/Oncologist, and Associate Professor of Medicine, Harvard Medical School, and Dana-Farber Cancer Institute.

Armin Schwartzman, Ph.D.; Assistant Professor of Biostatistics, Harvard School of Public Health, and Dana-Farber Cancer Institute.

Glorian Sorensen, Ph.D.; Professor of Society, Human Development, and Health, Harvard School of Public Health, and Dana-Farber Cancer Institute.

Donna Spiegelman, Sc.D.; Professor of Epidemiologic Methods, Harvard School of Public Health, and Channing Laboratory, Department of Medicine, Brigham and Women's Hospital.

Meir Stampfer, Dr.P.H., M.D.; Professor of Nutrition and Epidemiology, Harvard School of Public Health, and Channing Laboratory, Department of Medicine, Brigham and Women's Hospital.

Jane Weeks, M.D.; Professor in the Department of Health Policy and Management, Harvard School of Public Health and Dana-Farber Cancer Institute, and Professor of Medicine, Harvard Medical School.

Alan Zaslavsky, Ph.D.; Professor of Health Care Policy (Statistics), Harvard Medical School.

Marvin Zelen, Ph.D.; Lemuel Shattuck Research Professor of Statistical Science and Member of the Faculty of Arts and Sciences, Harvard School of Public Health, and Dana-Farber Cancer Institute.